Molecular interaction of Agouti protein and Agouti-related protein with human melanocortin receptors.
Tota. M R MR; Smith. T S TS; Mao. C C; MacNeil. T T; Mosley. R T RT; Van der Ploeg. L H LH; Fong. T M TM
Key Findings
- AGRP and Agouti protein act as antagonists of melanocortin‑3 and melanocortin‑4 receptors
- Cyclic octapeptides based on the AGRP loop function as MC4R antagonists, with lower affinity for MC3R
- The RFF111‑113 sequence and the Cys‑110 to Cys‑117 loop are critical for binding strength
Practical Outcomes
- For biohackers, this suggests that short, cyclic peptide fragments could be used to blunt the effects of melanotan‑I or other MC4R agonists, but the research is still early and doesn’t provide dosing or safety guidance. It’s mainly a mechanistic insight rather than a ready‑to‑use protocol.
Summary
The study shows that tiny circular pieces of a protein called AGRP can block the same receptors that the tanning peptide melanotan‑I activates. These short peptides bind better to the MC4R receptor than to MC3R, and a specific three‑letter segment (RFF) is especially important for this blocking action.
Abstract
Agouti protein and the Agouti-related protein (AGRP) are antagonists of the melanocortin-3 receptor and melanocortin-4 receptor. Both proteins contain 10 cysteines in the C-terminal domain arranged in five disulfide bonds. One possible arrangement of the disulfide bonds predicts an octapeptide loop, and the chemical properties of four residues within this loop (residues 111-114 in human AGRP) bear striking resemblance to those of several melanocortin peptides, including alpha-MSH, MT-II, and SHU-9119. We showed that cyclic synthetic octapeptides based on the sequence of this loop from Agouti protein or human AGRP are functional antagonists of the human melanocortin-4 receptor. All peptides had a lower affinity for the melanocortin-3 receptor than for the melanocortin-4 receptor. Substitution of serines for cysteines resulted in linear peptides which had reduced binding affinities for both receptors. Mutational analysis of human AGRP indicated that its C-terminal domain is functionally equivalent to the intact human AGRP. The RFF111-113 triplet appears to be the most critical portion of AGRP in determining the binding affinity for both melanocortin-3 and melanocortin-4 receptors. These data strongly suggest that the loop defined by Cys-110 and Cys-117 is critical in determining the antagonist activity of human AGRP. Our data provide indirect evidence for the suggestion that the Cys-110 to Cys-117 octapeptide loop of human AGRP mimics the conformation of alpha-MSH, MT-II, and SHU-9119.
Study Information
pubmed
1999
1999-01-19T00:00:00.000Z
10.1021/bi9815602